Charles River Laboratories Publishes 2023 Corporate Citizenship Report

Charles River Laboratories International, Inc. (NYSE: CRL) today announced the publication of its 2023 Corporate Citizenship Report, which includes progress and results from 2022 and 2023. The 2023 report demonstrates Charles River’s priorities and commitments across its strategic Environmental, Social and Governance (ESG) areas of focus: Accelerate Life-Saving Therapies; Lead with Integrity; Inspire our People; and Protect our Planet.

“The work we do at Charles River today extends beyond science. With more than 21,000 employees, our collective efforts are powerful, and our influence is transforming the biopharmaceutical industry to make a difference for both patients and the planet,” said James C. Foster, Chair, President, and Chief Executive Officer of Charles River. “We are proud of the progress we have made on our ESG commitments while working together to develop treatments that can save lives.”

Published every two years, the report highlights Charles River’s progress towards its ambitious Corporate Citizenship goals, as well as new milestones and accomplishments:

Accelerate Life-Saving Therapies

Charles River is committed to bringing effective medicines to patients safely and as quickly as possible and continues to be a trusted, global scientific partner of choice:

• Worked on 80% of the drugs approved by the U.S. Food and Drug Administration (FDA) in the past five years (2019-2023) and 85% of the drugs approved by the FDA in 2023 alone.
• Invested more than $4.5 billion in strategic acquisitions since 2012 to ensure clients have access to emerging therapies and technologies that help bring safe, effective treatments to market faster.
• Launched the Apollo technology solution, providing clients with access to an industry-leading, secure, cloud-based platform housing study data, study milestones, documents, cost estimates, and program planning tools.

Lead with Integrity

Making a positive impact on patients, animals in its care, and communities where employees work is central to Charles River’s ethos. During the 2022-2023 period, the Company:

• Established a Responsible Animal Use Committee of the Company's Board of Directors and the Office for Responsible Animal Usage (ORAU) to oversee responsible animal utilization and reduction practices, and operating standards of care.
• Further demonstrated its commitment to the 3Rs Principle – Replacement, Reduction, and Refinement – by spearheading the addition of a foundational fourth R, Responsibility – ultimately establishing the 4Rs to bring renewed focus to its commitment to animal welfare.
• Became a signatory to the United Nations Global Compact (UNGC).
• Received ISO 27001 certification, the international standard for information security management systems (ISMS), in 2023.

Inspire our People